Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
San Francisco, United States · Founded 2023 · $500K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2023
- Website
- velorumtx.com
- Total Funding
- $500K
- Last Round
- $500K Pre-SeedFeb 2024
- Rounds
- 1
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Summary
Velorum Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $500K in total across 1 round, most recently a $500K Pre-Seed round in Feb 2024. Investors include Y Combinator, 468 Capital and Jaan Tallinn.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Investors
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/velorumtx"><img src="https://indexed.vc/api/badge/company/velorumtx" alt="Velorum Therapeutics on Indexed.vc" width="260" height="76" /></a>

